Drug Shortage Report for MERSYNDOL WITH CODEINE

Last updated on 2023-07-10 History
Report ID 191773
Drug Identification Number 02047667
Brand name MERSYNDOL WITH CODEINE
Common or Proper name MERSYNDOL
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) ACETAMINOPHEN DOXYLAMINE SUCCINATE CODEINE PHOSPHATE
Strength(s) 325MG 5MG 8MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-05-08
Actual start date 2023-05-08
Estimated end date 2023-07-07
Actual end date 2023-07-07
Shortage status Resolved
Updated date 2023-07-10
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2023-07-10 French Compare
v12 2023-07-10 English Compare
v11 2023-07-10 French Compare
v10 2023-07-10 English Compare
v9 2023-06-30 French Compare
v8 2023-06-30 English Compare
v7 2023-06-05 French Compare
v6 2023-06-05 English Compare
v5 2023-05-09 English Compare
v4 2023-05-05 French Compare
v3 2023-05-05 English Compare
v2 2023-05-05 English Compare
v1 2023-05-05 English Compare

Showing 1 to 13 of 13